text
"['\n4. 매출 및 수주상황\n가. 매출실적 ( 내부거래 제거전 현황임. \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 단, 제일약품 매출 현황은 연결 매출액 기준으로 작성)\n(단위 :천원 \xa0)\n사업부문\n매출유형\n품 목\n\xa0제64기연간\n\xa0제63기연간\n\xa0제62기연간\n의약품제조\n제품\n케펜텍\n수출\n9,900,944\n11,171,437\n8,673,228\n내수\n5,949,498\n5,557,305\n7,081,553\n합계\n15,850,442\n16,728,742\n15,754,781\n쿨파프\n수출\n2,405,869\n2,703,966\n-\n내수\n1,755,016\n511,847\n2,003,977\n합계\n4,160,885\n3,215,813\n2,003,977\n티에스원\n내수\n4,728,027\n4,837,090\n5,454,509\n넥실렌\n내수\n9,021,663\n8,119,548\n10,197,180\n크라비트\n수출\n219,033\n210,641\n183,682\n내수\n5,882,351\n5,031,389\n4,321,967\n합계\n6,101,384\n5,242,030\n4,505,649\n베라실\n내수\n7,525,718\n6,210,710\n5,817,961\n란스톤캡슐\n내수\n7,215,395\n7,501,507\n6,650,092\n스타브론\n내수\n5,216,617\n5,079,411\n5,968,898\n비유피-4\n내수\n6,686,889\n5,448,142\n6,245,158\n옴니세프\n내수\n2,393,457\n3,568,810\n3,523,816\n리피토플러스\n내수\n14,109,669\n7,510,322\n3,359,900\n기타\n수출\n20,600,370\n23,049,246\n21,779,785\n내수\n84,201,523\n74,867,509\n66,658,182\n합계\n104,801,893\n97,916,755\n88,437,967\n소계\n수출\n33,126,216\n37,135,290\n30,636,695\n내수\n154,685,823\n134,243,590\n127,283,193\n합계\n187,812,039\n171,378,880\n157,919,888\n상품\n리피토\n내수\n172,912,239\n182,910,705\n176,606,941\n리리카\n내수\n77,170,802\n72,077,548\n66,982,277\n쎄레브렉스\n내수\n48,519,201\n47,876,800\n47,318,842\n란스톤엘에프디티\n내수\n23,675,996\n24,629,539\n29,921,078\n뉴론틴\n내수\n24,160,933\n23,976,814\n23,741,407\n카듀엣\n내수\n17,659,657\n18,487,639\n18,484,886\n덱실란트 디알 캡슐\n내수\n19,725,106\n20,973,859\n17,528,588\n진정주비타\n내수\n1,065,247\n3,320,756\n1,175,581\n투엑스비 듀얼\n내수\n2,692,664\n3,481,568\n3,104,482\n한방파프수\n내수\n4,972,975\n3,340,254\n2,934,782\n록펜텍\n내수\n2,019,028\n1,387,109\n1,309,579\n기타\n수출\n739,466\n24,471,452\n364,948\n내수\n184,781,414\n185,867,369\n205,208,579\n합계\n185,520,880\n210,338,821\n205,573,527\n소계\n수출\n739,466\n24,471,452\n364,948\n내수\n579,355,262\n588,329,960\n594,317,022\n합계\n580,094,728\n612,801,412\n594,681,970\n기타\n수탁매출외\n내수\n24,836,624\n5,605,600\n3,725,307\n지주사외\n기타\n경영자문\n내수\n4,035,697\n3,832,254\n3,660,158\n임대료\n내수\n5,029,031\n4,874,296\n4,929,904\n지분법수익\n내수\n4,622,649\n2,907,054\n3,328,312\n판매대행\n내수\n25,656,158\n23,495,232\n23,211,328\n합 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0계\n수출\n33,865,682\n61,606,742\n31,001,643\n내수\n798,221,244\n763,287,986\n760,455,224\n합계\n832,086,926\n824,894,728\n791,456,867\n나. 판매경로 및 판매방법 등\n(1) 판매경로\n\xa0[제일약품] \xa0 \xa0 원외 \xa0 \xa0 \xa0 : \xa0 84.4% \xa0 \xa0 \xa0 종합병원 : \xa0 \xa09.3% \xa0 \xa0 \xa0 \xa0 \xa0관계사 \xa0 \xa0: \xa0 \xa0 0.6%  \xa0 \xa0 기타 \xa0 \xa0 \xa0 : \xa0 \xa03.0% \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0 \xa0 : \xa0 \xa02.7% [제일헬스사이언스] \xa0 약국 \xa0 \xa0: \xa0 58.0% \xa0 \xa0 \xa0 \xa0 \xa0 도매 \xa0 \xa0: \xa0 \xa09.0% \xa0 \xa0 \xa0 \xa0 \xa0특판 \xa0 \xa0: \xa0 \xa05.7%  \xa0기타 \xa0 \xa0: \xa0 \xa0 7.2% \xa0 \xa0 \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0: \xa0 \xa020.1%\n(2) 판매방법 및 조건\n\xa0 방법 : 주문판매 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0조건 : 외상매출후 현금, 어음, 카드등 수금\n']"
